Generation of four human pluripotent stem cell lines harboring OPA1-related optic atrophy variant

Summary

We have generated four human iPSC lines from skin biopsy-derived fibroblast cells with pathogenic variants in OPA1. Donors have a clinical diagnosis of optic atrophy. Three harbor heterozygous presumed loss-of-function (pLOF) variants, c.1608 + 1_1608 + 6delGTGAGG; c.2873_2876delTTAG; and c.635_636delAA; one patient is compound heterozygous for a nonsense allele c.676C>T p. (Gln226Ter) and a missense modifier allele c.1146A>G p.(Ile382Met). All iPSC lines were reprogrammed using non-integrating Sendai virus techniques and validated with undifferentiated hPSC state markers at RNA and protein level. OPA1 iPSC lines differentiate into retinal ganglion-like cells, providing a useful platform to study pathogenesis and development of cell-based drug screens. Published by Elsevier B.V.

Authors Li Z, Yousaf S, Guan B, Naik A, Villasmil R, Oh RS, Liau G, Fufa TD, Huryn LA, Hufnagel RB
Journal Stem cell research
Publication Date 2025 Sep;87:103766
PubMed 40738073
PubMed Central PMC12456368
DOI 10.1016/j.scr.2025.103766

Research Projects

Cell Lines